Skip to content

Accounts Payable at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$793.15M+26.3%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$11.69M-34.4%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$13.49M+177%
XER
Xeris Biopharma Holdings, Inc.XERS
$11.47M+80.5%
PVL
Palvella TherapeuticsPVLA
$5.44M+22.6%
PTC Therapeutics logo
PTC TherapeuticsPTCT
$313.05M-1.5%

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$132.59M-87.6%

Returns & leverage

See full
Return on equity-1,209.8%
Current ratio3.5×

Where this comes from

Reported directly by Polaryx Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.

The official record: Polaryx Therapeutics, Inc. ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Polaryx Therapeutics, Inc. 's accounts payable.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Polaryx Therapeutics, Inc. 's accounts payable?
Polaryx Therapeutics, Inc. (PLYX) reported accounts payable of $850K in Q1 2026.
How has Polaryx Therapeutics, Inc. 's accounts payable changed year-over-year?
Polaryx Therapeutics, Inc. 's accounts payable increased by 5100.0% year-over-year, from -$17K to $850K.
What does accounts payable mean?
Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.